Pharma

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Myriad Genetics, Inc. announced the launch of OnDose, the Company's seventh molecular diagnostic product. OnDose utilizes a unique, proprietary technology to measure a patient's exposure to the chemotherapy drug, 5–Fluorouracil (5–FU), to help oncologists adjust and optimize dosing to maximize efficacy and reduce toxicity.


Today in Medical Devices/Products...keeping you current

AstraZeneca submits US New Drug Application for ticagrelor, an investigational antiplatelet agent
AstraZeneca, 11/23/09

FDA Grants Emergency Use Authorization of the Prodesse ProFlu-ST(TM)
Gen-Probe, 10/30/09

Gyrus PlasmaKinetic bipolar coagulation device for liver resection
Australian and New Zealand Journal of Surgery, 11/13/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address